Maak kennis met Kirian Claeyé

Telephone:
+32 2 426 14 14
Email:
kirian.claeye@altius.com

Kirian is gespecialiseerd in Intellectuele Eigendom (IE)  en regelgevingszaken, met een bijzondere focus op voeding, farma en life sciences.

Zijn IE-werkzaamheden omvatten complexe octrooiprocessen, vaak met betrekking tot grensoverschrijdende kwesties, en ondersteuning en advies met betrekking tot IE-portefeuillebeheer.

Zijn regelgevende zaken gaan van procedures in het domein van klinische testen, lancerings– en marketingstrategieën tot tarifering en terugbetaling, aanbestedingen en lifecycle management.

Kirian behaalde zijn masterdiploma in de rechten aan de Universiteit Gent (magna cum laude).

Na drie jaar werken in de IE-sector deed Kirian nog extra internationale ervaring op door een postgraduaat te volgen aan de Berkeley School of Law (Universiteit van Californië), waar hij ook het Law and Technology Certificate heeft behaald.

Kirian is ook lid van Boalt Hall Alumni Association, de Benelux Association for Trademark and Design Law en International Association for the Protection of Intellectual Property.

Bovendien spreekt hij regelmatig op conferenties en seminaries.

Opleiding
  • Master in Law (University of Ghent)
  • LL.M. (University of California, Berkeley School of Law)
  • Law and Technology Certificate (University of California)
Talen
  • Kirian spreekt vloeiend Nederlands, Engels en Frans
Een selectie publicaties
  • “Evoluties in het octrooirecht – Overzicht van rechtspraak 2018-2022”, [to be published before summer 2022] (with P. de Jong and C. Ronse)
  • “Vrijwaring voor uitwinning en intellectuele eigendom” in B. Tilleman & B. Devolder, Weens Koopverdrag, Brugge, Die Keure, 2022, pp. 551-618 (with L. Traest)
  • “Pharmaceutical IP and Competition law in Belgium: Overview”, Thomson Reuters, 1 August 2021 (with B. Gielen)
  • “Must AstraZeneca supply the EU with sufficient COVID-19 vaccines?”, ILO Healthcare & Life Sciences, 10 February 2021 / Mondaq, 13 April 2021
  • “Belgium” in J. Bühling, Patent Protection for Second Medical Uses, The Netherlands, Kluwer, 2020 (with C. Ronse)
  • The Pharma Legal Handbook: Belgium, PharmaBoardroom 2020 (with C. Ronse)
  • “Evoluties in het octrooirecht – Overzicht van rechtspraak 2014-2018”, TBH-RDC 2018, 747-798 (with P. de Jong and C. Ronse)
Wat onze cliënten zeggen over ons

“Kirian Claeyé is a hands-on lawyer who combines practical knowledge with a deep understanding of the Belgian life sciences regulations.” – Legal 500 EMEA, 2024

“Kirian provides us with clear and useful advice.” –  Chambers Europe, 2024

“Kirian Claeyé has very strong expertise.” –  Chambers Europe, 2024

“He knows everything about the pharmaceutical sector.” –  Chambers Europe, 2024

“He is definitely a rising star.” –  Chambers Europe, 2024

“He is a very strong patent litigator with excellent strategy and communication skills.” – Chambers Europe, 2023

“Kirian Claeyé has thorough knowledge and provides very clear and useful advice, also on uncharted topics.” – Legal 500 EMEA, 2023

“Altius is excellent in patent litigation, especially with regards to pharma cases; very responsive and on the point. Kirian Claeye is an outstanding litigator.” – Legal 500 EMEA, 2023

“The ‘genius’ Kirian Claeyé is a key contact within the team for parallel import/distribution support and IP portfolio management across the life sciences sector.” – Legal 500 EMEA, 2022

“If I could, I’d give a 5 star rating to Kirian Claeyé who has proven to be a genius. We are working together a bit more than two years and time after time he solved our issues in a simple and eloquent way. Fast and clear communication and a complete risk analysis of the chosen strategy. For me, Kirian Claeyé has the charisma needed to guide you in each step and makes the legal aspect of our business fun, comprehensible and exciting.” – Legal 500 EMEA, 2022

Uitgeroepen tot “Key Lawyer” in Legal 500 (Intellectual Property and Healthcare & Life Sciences) in 2021 & 2022.

Brons in IAM Patent 1000 in 2021.

Uitgeroepen tot “Rising Star” in IP Stars in 2019, 2020 and 2021.

Aanbevolen in Who’s Who Legal (Life Sciences – Patent Litigation) in 2020 and 2021.

Uitgeroepen tot “Rising Life Sciences Star” door Expert Guides, 2018, 2019, 2020 and 2021

WWL Recommended